Not logged in Clinical Trial Data Review of the Combination FTD/TPI plus Bevacizumab in the Treatment Landscape of Unresectable Metastatic Colorectal Cancer Andre, Thierry; Van Cutsem, Eric; Taieb, Julien; Fakih, Marwan; Prager, Gerald W.; Ciardiello, Fortunato; Falcone, Alfredo; Saunders, Mark; Amellal, Nadia; Roby, Lucas; Tabernero, Josep; Pfeiffer, Per Share Save
Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C Study Shah, Manish A.; Yoshino, Takayuki; Tebbutt, Niall C.; Grothey, Axel; Tabernero, Josep; Xu, Rui-Hua; Cervantes, Andres; Oh, Sang Cheul; Yamaguchi, Kensei; Fakih, Marwan; Falcone, Alfredo; Wu, Christina; Chiu, Vi K.; Tomasek, Jiri; Bendell, Johanna; Fontaine, Marilyn; Hitron, Matthew; Xu, Bo; Taieb, Julien; Van Cutsem, Eric Share Save
Impact of genetic variants involved in the lipid metabolism pathway on progression free survival in patients receiving bevacizumab-based chemotherapy in metastatic colorectal cancer: a retrospective analysis of FIRE-3 and MAVERICC trials Wang, Jingyuan; Millstein, Joshua; Yang, Yan; Stintzing, Sebastian; Arai, Hiroyuki; Battaglin, Francesca; Kawanishi, Natsuko; Soni, Shivani; Zhang, Wu; Mancao, Christoph; Cremolini, Chiara; Liu, Tianshu; Heinemann, Volker; Falcone, Alfredo; Shen, Lin; Lenz, Heinz-Josef Share Save
Trifluridine-tipiracil plus bevacizumab versus capecitabine plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer ineligible for intensive therapy (SOLSTICE): a randomised, open-label phase 3 study Andre, Thierry; Falcone, Alfredo; Shparyk, Yaroslav; Moiseenko, Fedor; Polo-Marques, Eduardo; Csoszi, Tibor; Campos-Bragagnoli, Arinilda; Liposits, Gabor; Chmielowska, Ewa; Aubel, Paul; Martin, Lourdes; Fougeray, Ronan; Amellal, Nadia; Saunders, Mark P. Share Save
Pooled safety analysis from phase III studies of trifluridine/tipiracil in patients with metastatic gastric or gastroesophageal junction cancer and metastatic colorectal cancer Van Cutsem, E.; Hochster, H.; Shitara, K.; Mayer, R.; Ohtsu, A.; Falcone, A.; Yoshino, T.; Doi, T.; Ilson, D. H.; Arkenau, H-T; George, B.; Benhadji, K. A.; Makris, L.; Tabernero, J. Share Save
Genetic variants involved in the cGAS-STING pathway predict outcome in patients with metastatic colorectal cancer: Data from FIRE-3 and TRIBE trials Wang, Jingyuan; Xiao, Yi; Loupakis, Fotios; Stintzing, Sebastian; Yang, Yan; Arai, Hiroyuki; Battaglin, Francesca; Kawanishi, Natsuko; Jayachandran, Priya; Soni, Shivani; Zhang, Wu; Mancao, Christoph; Cremolini, Chiara; Liu, Tianshu; Heinemann, Volker; Falcone, Alfredo; Shen, Lin; Millstein, Joshua; Lenz, Heinz-Josef Share Save
First-line trifluridine/tipiracil plus bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study Van Cutsem, E.; Danielewicz, I; Saunders, M. P.; Pfeiffer, P.; Argiles, G.; Borg, C.; Glynne-Jones, R.; Punt, C. J. A.; Van de Wouw, A. J.; Fedyanin, M.; Stroyakovskiy, D.; Kroening, H.; Garcia-Alfonso, P.; Wasan, H.; Falcone, A.; Fougeray, R.; Egorov, A.; Amellal, N.; Moiseyenko, V Share Save
Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment Conte, P.; Ascierto, P. A.; Patelli, G.; Danesi, R.; Vanzulli, A.; Sandomenico, F.; Tarsia, P.; Cattelan, A.; Comes, A.; De Laurentiis, M.; Falcone, A.; Regge, D.; Richeldi, L.; Siena, S. Share Save
A pharmacogenetic interaction analysis of bevacizumab with paclitaxel in advanced breast cancer patients Coltelli, Luigi; Allegrini, Giacomo; Orlandi, Paola; Finale, Chiara; Fontana, Andrea; Masini, Luna Chiara; Scalese, Marco; Arrighi, Giada; Barletta, Maria Teresa; De Maio, Ermelinda; Banchi, Marta; Fini, Elisabetta; Guidi, Patrizia; Frenzilli, Giada; Donati, Sara; Giovannelli, Simona; Tanganelli, Lucia; Salvadori, Barbara; Livi, Lorenzo; Meattini, Icro; Pazzagli, Ilaria; Di Lieto, Marco; Pistelli, Mirco; Casadei, Virginia; Ferro, Antonella; Cupini, Samanta; Orlandi, Francesca; Francesca, Damiana; Lorenzini, Giulia; Barellini, Leonardo; Falcone, Alfredo; Cosimi, Alessandro; Bocci, Guido Share Save
Triplet chemotherapy in combination with anti-EGFR agents for the treatment of metastatic colorectal cancer: Current evidence, advances, and future perspectives Folprecht, Gunnar; Martinelli, Erika; Mazard, Thibault; Modest, Dominik P.; Tsuji, Akihito; Esser, Regina; Cremolini, Chiara; Falcone, Alfredo Share Save
Rationale and Study Design of the PARERE Trial: Randomized phase II Study of Panitumumab Re-Treatment Followed by Regorafenib Versus the Reverse Sequence in RAS and BRAF Wild-Type Chemo-Refractory Metastatic Colorectal Cancer Patients Moretto, Roberto; Rossini, Daniele; Capone, Iolanda; Boccaccino, Alessandra; Perrone, Federica; Tamborini, Elena; Masi, Gianluca; Antoniotti, Carlotta; Marmorino, Federica; Conca, Veronica; Borelli, Beatrice; Martignetti, Angelo; Pecora, Irene; Simionato, Francesca; Cupini, Samanta; Ambrosini, Margherita; Manca, Paolo; Pietrantonio, Filippo; Falcone, Alfredo; Cremolini, Chiara Share Save
Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies by GONO Rossini, D.; Boccaccino, A.; Sbrana, A.; Daniel, F.; Borelli, B.; Raimondi, A.; Santini, D.; Conca, V; Tomasello, G.; Caponnetto, S.; Marmorino, F.; Zaniboni, A.; Buonadonna, A.; Masi, G.; Lonardi, S.; Pietrantonio, F.; Falcone, A.; Antonuzzo, A.; Cremolini, C. Share Save
Detailing the ultrastructure's increase of prion protein in pancreatic adenocarcinoma Bianchini, Matteo; Giambelluca, Maria Anita; Scavuzzo, Maria Concetta; Di Franco, Gregorio; Guadagni, Simone; Palmeri, Matteo; Furbetta, Niccolo; Gianardi, Desiree; Funel, Niccola; Ricci, Claudio; Gaeta, Raffaele; Pollina, Luca Emanuele; Falcone, Alfredo; Vivaldi, Caterina; Di Candio, Giulio; Biagioni, Francesca; Busceti, Carla Letizia; Morelli, Luca; Fornai, Francesco Share Save
Original Research Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 study Antoniotti, Carlotta; Korn, W. Michael; Marmorino, Federica; Rossini, Daniele; Lonardi, Sara; Masi, Gianluca; Randon, Giovanni; Conca, Veronica; Boccaccino, Alessandra; Tomasello, Gianluca; Passardi, Alessandro; Swensen, Jeff; Ugolini, Clara; Oberley, Matthew; Tamburini, Emiliano; Casagrande, Mariaelena; Domenyuk, Valeriy; Fontanini, Gabriella; Giordano, Mirella; Abraham, Jim; Spetzler, David; Falcone, Alfredo; Lenz, Heinz-Josef; Cremolini, Chiara Share Save
Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications Moretto, Roberto; Elliott, Andrew; Zhang, Jian; Arai, Hiroyuki; Germani, Marco Maria; Conca, Veronica; Xiu, Joanne; Stafford, Phillip; Oberley, Matthew; Abraham, Jim; Spetzler, David; Rossini, Daniele; Antoniotti, Carlotta; Marshall, John; Shields, Anthony; Lopes, Gilberto; Lonardi, Sara; Pietrantonio, Filippo; Tomasello, Gianluca; Passardi, Alessandro; Tamburini, Emiliano; Santini, Daniele; Aprile, Giuseppe; Masi, Gianluca; Falcone, Alfredo; Lenz, Heinz-Josef; Korn, Michael; Cremolini, Chiara Share Save
FOLFOXIRI plus bevacizumab (bev) plus atezolizumab (atezo) versus FOLFOXIRI plus bev as first-line treatment of unresectable metastatic colorectal cancer (mCRC) patients: Results of the phase II randomized AtezoTRIBE study by GONO Cremolini, C.; Rossini, D.; Antoniotti, C.; Pietrantonio, F.; Lonardi, S.; Salvatore, L.; Marmorino, F.; Borelli, B.; Ambrosini, M.; Barsotti, G.; Di Stefano, B.; Masi, G.; Boccaccino, A.; Tamberi, S.; Tamburini, E.; Frassineti, L. G.; Simionato, F.; Fontanini, G.; Boni, L.; Falcone, A. Share Save
Comparison between first-line target therapy and immunotherapy in different prognostic categories of BRAF mutant metastatic melanoma patients Marconcini, R.; Fava, P.; De Rosa, F.; De Tursi, M.; Tanda, E. T.; Consoli, F.; Targato, G.; Pimpinelli, N.; Morgese, F.; Bersanelli, M.; Tucci, M. G.; Saponara, M.; Cortellini, A.; Ocelli, M.; Morganti, R.; Manacorda, S.; Bazzurri, S.; Nuzzo, A.; Ferrari, M.; Falcone, A. Share Save
Exploring clinical and gene expression markers of benefit from FOLFOXIRI/bevacizumab in patients with BRAF-mutated metastatic colorectal cancer: Subgroup analyses of the TRIBE2 study Moretto, Roberto; Giordano, Mirella; Poma, Anello M.; Passardi, Alessandro; Boccaccino, Alessandra; Pietrantonio, Filippo; Tomasello, Gianluca; Aprile, Giuseppe; Lonardi, Sara; Conca, Veronica; Granetto, Cristina; Frassoldati, Antonio; Clavarezza, Matteo; Bertolini, Alessandro S.; Germani, Marco M.; Ugolini, Clara; Fontanini, Gabriella; Masi, Gianluca; Falcone, Alfredo; Cremolini, Chiara Share Save
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies Moretto, Roberto; Rossini, Daniele; Conca, Veronica; Lonardi, Sara; Rasola, Cosimo; Antoniotti, Carlotta; Santini, Daniele; Marmorino, Federica; Tomasello, Gianluca; Borelli, Beatrice; Caponnetto, Salvatore; Zucchelli, Gemma; Zaniboni, Alberto; Ambrosini, Margherita; Buonadonna, Angela; Fanchini, Laura; Cupini, Samanta; Masi, Gianluca; Falcone, Alfredo; Cremolini, Chiara Share Save
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: Final results according to duration of treatment from the phase IIIb, international, open-label, early-access PRECONNECT study Taieb, J.; Price, T.; Wyrwicz, L.; Vidot, L.; Raimond-Thibaut, A.; Chrostek, H.; Bachet, J.; Falcone, A. Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
